- Report
- April 2025
- 50 Pages
Global
From €2496EUR$2,650USD£2,135GBP
- Report
- April 2025
- 200 Pages
Global
From €4229EUR$4,490USD£3,617GBP
Mebendazole is an anthelmintic drug used to treat a variety of parasitic worm infections, including roundworm, hookworm, whipworm, pinworm, and others. It is commonly used in the treatment of infectious diseases caused by these parasites, such as ascariasis, trichuriasis, and enterobiasis. Mebendazole works by inhibiting the growth of the worms, causing them to die off. It is available in both oral and topical forms, and is generally well-tolerated with few side effects.
Mebendazole is widely used in the treatment of parasitic worm infections, and is available in many countries around the world. It is often prescribed as a first-line treatment for these infections, due to its effectiveness and low cost. It is also used in combination with other drugs to treat more severe infections.
In the Mebendazole market, some of the major players include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Bayer. Other companies involved in the market include Novartis, Johnson & Johnson, and Teva Pharmaceuticals. Show Less Read more